Small Stocks, Big Money

ASP Isotopes (NASDAQ: ASPI) is an isotope enrichment company utilizing technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses. Many of these elements are unsuitable for enrichment using traditional methods such as centrifuges. The Company is initially focused on commercializing Molybdenum 100, which has the potential to replac...

American Resources Corp. (NASDAQ: AREC) is building one of the most unique growth platforms to strategically align old-world, legacy assets with a more modern economy. The Company is focused on extracting and processing metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. American R...

QYOU Media (OTCQB: QYOUF) has added to the depth and breadth of its products and capabilities throughout 2022. With five active channels now in India and the addition of ChtrSocial in India and Q Studios in the US, QYOU Media is rapidly advancing its push towards driving increased audience size and strong revenue growth in 2023 and beyond. Building on a solid foundation with accelerating momentum...

Aridis (OTC: ARDS) is revolutionizing how we treat infectious diseases through its unique technology platforms, which can quickly detect human-derived mAbs to treat infectious diseases. The Company's transformative approach utilizes a patient's own immune system to identify mAbs capable of fighting infections and underpins multiple late-stage programs. In January, Aridis announced positive top-lin...

Learn about Sixty Degrees Pharma (Nasdaq: SXTP) from CEO Geoff Dow. In this exclusive interview with Dow, gain insight into the company's mission to develop and commercialize new therapies for a range of infectious diseases, including its FDA-approved malaria preventative treatment ARAKODA® and the Company's current pipeline development programs for Tafenoquine and Celgosivir targeting COVID-19, f...

BioVie is poised for significant catalysts in 2023, including data read out from its Alzheimer’s Phase 3 trial, expected in Q3 2023, as well as interim data read outs from the Company’s planned Phase 3 study in Parkinson’s. BioVie has multiple other efforts underway that may create additional catalysts and will be announced publicly when the Company deems appropriate. Learn more at: https://www.re...

Meet the Founder & CEO of Bullfrog AI (NASDAQ:BFRG) Vin Singh as he delves deep into his personal life and how those choices help shape the precision medicine company that uses AI and machine learning to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. RedChip Companies, Inc. research reports, company prof...

Meet the CEO of American Resources Corporation (NASDAQ:AREC) Mark Jensen as he delves deep into his personal life and how those choices help shape the building of one of the most unique growth platforms to strategically align old-world, legacy assets with a more modern economy. RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presen...

Rail Vision (NASDAQ: RVSN) is the leading provider of obstacle detection and classification systems in the railway industry. With the Company’s unique cognitive sensor fusion technology, based on advanced electro-optic sensors, artificial intelligence and deep learning, Rail Vision systems detect objects on and along the tracks from a distance of up to two kilometers – in real time – as well as in...

American Resources Corp. (NASDAQ: AREC) is building one of the most unique growth platforms to strategically align old-world, legacy assets with a more modern economy. The Company is focused on extracting and processing metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. American R...

Delivering competitive, clean energy solutions to customers for more than 15 years, SPI Energy (NASDAQ: SPI) is an established renewable energy player with global operations in key markets in Asia, Australia, North America, and Europe. Since 2006, SPI has been a leading solar project developer, delivering competitive, clean energy solutions to customers across the U.S. and globally. The company ha...

BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative disease, the Company’s drug candidate NE3107 inhibits inflammatory activation of ERK and NFkB (e.g., TNF signaling) that leads to neuroinflammation and insulin resistance, but not their homeost...

Zomedica (NYSE American: ZOM) is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians. With modest cash burn and a strong balance sheet, including $156 million cash, cash equivalents, and a...

Listen to this episode! RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the p...

Founded in 2017, Continental Lithium commenced small-scale mining in collaboration with artisanal miners in 2018. Over the last five years, the underlying assets acquired by Continental Lithium have produced approximately 15,000 metric tons of lithium concentrate. The Company has plans to develop its lithium and rare earth mineral assets and substantially increase its production for export to the...

Reviva (Nasdaq: RVPH) is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva's current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva's pipeline currently has two drug c...

BullFrog AI (Nasdaq: BFRG) is a precision medicine company using AI and machine learning to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development using its...

QYOU Media (OTCQB: QYOUF) has added to the depth and breadth of its products and capabilities throughout 2022. With five active channels now in India and the addition of ChtrSocial in India and Q Studios in the US, QYOU Media is rapidly advancing its push towards driving increased audience size and strong revenue growth in 2023 and beyond. Building on a solid foundation with accelerating momentum...

Sharps Technology (Nasdaq: STSS) is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation. Sharps Provensa™ is the Company’s premier line of smart safety syringes that eliminate accidental needlestick injuries, prevent improper needle reuse, and reduce wasted medicine and vaccines—while ret...

Graphex Group (NYSE American: GRFX) is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases. With over a decade of production experience operating at commercial-scale volumes and quality, Graphex is cur...

Lantern Pharma (Nasdaq: LTRN) is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. The Company’s proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing t...